Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Provention Bio Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
PRVB
Nasdaq
2836
https://www.proventionbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Provention Bio Inc
MacroGenics, Inc. (NASDAQ:MGNX) Q4 2022 Earnings Call Transcript
- Mar 18th, 2023 6:52 am
Why Provention Bio Stock Skyrocketed 256% This Week
- Mar 16th, 2023 8:56 pm
Q4 2022 MacroGenics Inc Earnings Call
- Mar 16th, 2023 11:10 am
Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi
- Mar 14th, 2023 4:32 pm
Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners
- Mar 13th, 2023 11:15 pm
These Stocks Are Moving the Most Today: First Republic, Schwab, Seagen, Provention Bio, Illumina, and More
- Mar 13th, 2023 8:16 pm
Seagen Nabs $43 Billion Pfizer Deal; Sanofi Scoops Up Provention Bio
- Mar 13th, 2023 8:10 pm
Regional banks pace decliners after bank failures, as biotech deals lift Seagen and Provention Bio
- Mar 13th, 2023 7:22 pm
Pfizer Agrees to Buy Seagen for $43 Billion
- Mar 13th, 2023 7:06 pm
Provention Bio's $2.9B Acquisition - A Strategic Fit For Sanofi
- Mar 13th, 2023 5:04 pm
Provention Bio Stock Soars on $2.9 Billion Acquisition by Sanofi
- Mar 13th, 2023 3:38 pm
Pfizer Rolls the Dice on Seagen in $43 Billion Deal. The Risks It Faces.
- Mar 13th, 2023 2:07 pm
Sanofi Agrees to Pay $2.9 Billion For Provention Bio
- Mar 13th, 2023 1:45 pm
Sanofi agrees to $2.9B purchase of Provention Bio in bid to boost diabetes drug
- Mar 13th, 2023 11:37 am
Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
- Mar 13th, 2023 11:00 am
Sanofi to buy Provention Bio in deal worth $2.9 billion
- Mar 13th, 2023 6:49 am
UPDATE 3-Sanofi hones in on type 1 diabetes in $2.9 bln Provention Bio deal
- Mar 13th, 2023 6:48 am
Sanofi hones in on type 1 diabetes in $2.9 billion Provention Bio deal
- Mar 13th, 2023 6:29 am
Will Provention Bio, Inc. (PRVB) Report Negative Earnings Next Week? What You Should Know
- Mar 9th, 2023 3:00 pm
Provention Bio Announces the Grant of Inducement Awards
- Mar 3rd, 2023 9:05 pm
Scroll